anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

206,761-206,820 of 319,975

filter-aware
09
The slide uses a list of icons to represent key clinical attributes of the drug candidate.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
The slide highlights the clinical need for new therapies due to resistance mutations (G2032R) and CNS involvement.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
11
The table uses a green background to indicate positive results ('Yes') and white for negative results ('No').Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · CompetitionLoop · Cost Of Inaction1 hit
12
The slide uses a human anatomy diagram to map specific TRK receptor inhibition side effects to body regions.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
The slide uses dot plots for IC50 data and a bar chart for in vivo efficacy, highlighting NVL-520's performance.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
14
The slide uses two distinct chart types to demonstrate efficacy: a bar chart for brain penetrance and a grouped bar chart for selectivity index.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
15
Includes a detailed table of Phase 2 cohorts and a list of study objectives.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
16
The slide details the transition from the All-Treated Population (N=35) to the NSCLC Response-Evaluable Population (N=21) through back-fill expansion.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
17
Data table showing demographics, tumor types, ECOG performance status, and prior treatment history including specific TKI therapies.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
18
Data as of 13 Sep 22. Table lists specific adverse events by grade.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
19
The chart displays dose-dependent exposure levels exceeding multiple target thresholds for ROS1 variants in CNS and periphery.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
20
Clinical trial data table showing efficacy metrics for a drug candidate.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
21
The chart uses a waterfall plot to visualize clinical efficacy, a standard in oncology drug development.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
22
The chart is a swimmer plot, commonly used in oncology clinical trials to visualize time-to-event data.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
23
Includes clinical trial data (ORR, tumor shrinkage, allele clearance) for a specific drug candidate.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
24
Includes MRI scan series showing lesion reduction over 8 weeks.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
25
Includes a timeline of treatments leading up to NVL-520 and radiological evidence of response.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
26
Clinical trial summary slide for Nuvalent's ARROS-1 study.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
27
The slide uses a list format to define the TPP, which is a standard pharmaceutical industry framework.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
28
The table highlights the progression of resistance mutations and the increasing prevalence of CNS disease as patients move through lines of therapy.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
29
The table uses a green/white color coding to highlight positive attributes of NVL-655 compared to competitors.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
30
The slide uses three distinct chart types to demonstrate efficacy, pharmacokinetics, and selectivity.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
31
The slide compares vehicle control against NVL-655 treatment in both bar chart (multiple models) and line chart (PDX model) formats.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
32
The slide outlines the study design for NVL-655, including dose levels for Phase 1 and specific inclusion criteria for Phase 2 cohorts (2a-2d).Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
33
The slide outlines the key therapeutic advantages of the drug candidate NVL-330.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
34
Includes three distinct charts: a dot plot for IC50, a bar chart for selectivity index, and a bar chart for brain penetrance.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
35
Nuvalent | Investor Presentation Deck | 39 slidesNuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
36
The slide uses a diagonal process flow with hexagonal containers.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
37
The slide uses a standard pharmaceutical pipeline visualization format.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
38
Includes a 3D molecular structure visualization.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
39
Includes a molecular structure visualization.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
01
Slide 1
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
02
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
03
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
04
This is a photograph of a real-world OOH (out-of-home) advertisement, not a standard slide deck page.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
05
The slide uses custom icons (thumbs up for the outgoing CEO, flexed-arm milk cartons for the incoming CEO) to denote leadership attributes.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
06
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Key Messages1 hit
07
The slide uses pink circles to highlight specific bps and dollar changes.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · KPI Overview1 hit
08
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
09
The slide uses a three-column layout to present category growth, market share trends, and customer logos.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
10
The slide uses photographic evidence of retail shelf placement and point-of-sale displays to support the thesis of market expansion.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
11
The slide uses a visual collage style to showcase OOH advertising and product activations.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
12
The slide uses a map to illustrate geographic expansion and a bar chart to quantify the impact of new markets on growth.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
13
The slide uses a simple matrix-like layout to categorize strategic initiatives.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
14
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
15
The slide uses three distinct chart types to illustrate commercial progress: bar charts for distribution and promotion, and a waterfall-style bar chart for share trends.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
16
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
17
The slide shows the same creative execution applied to two different media formats (billboard and print ad).Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
18
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
19
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
20
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
21
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Executive Summary1 hit
22
The slide uses a high-contrast, provocative brand image as a background for a financial presentation.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
23
The slide uses a typewriter-style font and includes footnotes regarding non-IFRS measures.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
24
The chart uses a waterfall bridge to explain the 18% YoY revenue growth.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
25
The slide uses a 'Constant Currency' framework to isolate operational growth from currency fluctuations.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
26
The chart uses a waterfall-bridge structure to explain the variance in gross margin percentage.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
27
The chart displays negative EBITDA values across regions and corporate, with a trend of narrowing losses over time.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
28
The slide uses a process-like flow to connect 2023 targets to a 2024 outcome.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit
29
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations 1 hit